The 21^st edition of BioAsia 2024, which is fast gearing up to be held at the Hyderabad International Convention Centre (HICC), in Madhapur, Hyderabad, is expected to witness lead industry experts from the Life Sciences, Healthcare, Biotech, and Pharma sectors to delve on the challenges and opportunities offered by new age technologies including Data and Artificial Intelligence (AI).

According to organisers, the three-day forum is expected to delve into various themes including  ‘Transformative Innovation – R&D, Patent Paradox: India's Bid for Global R&D Dominance & IP Dilemmas, Leading the Health-tech Revolution - The Next Normal, India at the Frontier of Pharma Services, MedTech is the place to be, etc.

It is understood from the organisers that this year’s event is expected to witness more than 3000 delegates participating from over 50 countries across the globe.

Organised by the Government of Telangana, the marquee healthcare and Life Sciences event is all set for the grand unveiling on February 26^th, 2024 and the extravagant industrial event is expected to draw crowds both nationally and internationally for the next two days on February 27 and 28^th.

As part of the preparations for the event, Duddilla Sridhar Babu, Minister for Information Technology, Industries & Commerce conducted a comprehensive review meeting with the concerned authorities and gave directions to make sure that the global event is held successfully highlighting the investment and business opportunities in the areas of Healthcare, Pharma, Biotech and Life sciences sector in Telangana.

"BioAsia has emerged as a critical instrument for the development of the Indian and global life science and allied industries over the last two decades. We are thrilled to announce that several global CEOs will be attending BioAsia for the first time, underlining the event's rising prominence on the international stage. My team and I are leaving no stone unturned to ensure that BioAsia 2024 is grand and impactful," observed the Telangana Industry and Commence Minister.

As a Global Flagship event of the Government of Telangana, BioAsia has emerged as a pivotal player in steering the life-sciences development journey in India, playing a crucial role in redirecting focus toward the advancements and challenges within the industry, observed Jayesh Ranjan, Principal Secretary, Department of Industries and commence government of Telangana. "Over the past 20 editions, BioAsia has played an unmatched role in sparking the renewed emphasis on the life-sciences industry, rekindling attention from regulation, corporate, startups, and allied sectors alike,” added Jayesh Ranjan, the Industry Principal secretary.

This year’s event is expected to present itself distinctly by featuring not just prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, but the organizers are also roping in more than 70 influential speakers, including global CEOs and industry leaders representing lead international life sciences and pharmaceutical companies.

Some of them include David Ricks (CEO, Eli Lilly and Company), Dr Christopher Boerner (Incoming CEO, Bristol Myers Squibb), Geoff Martha (Chairman and CEO, Medtronic), Prof. Gregg Semenza (Nobel Laureate & Professor at Johns Hopkins School of Medicine), among others. The event will also feature President and CEO, Olympus Stefan Kaufmann; CEO of Providence Dr Rod Hochman, M.D., Global Operating Partner of Advent International Stefan Stoffel, among others.

David Ricks of Eli Lilly and Company is expected to deliver a Keynote address for the event. With expectations soaring high with an extraordinary line-up of speakers, BioAsia 2024 is projected to attract over 3000 participants, offering a dynamic platform for networking and collaboration. Further, the event will have an exhibition this year with more than 200 companies participating to showcase some of the most innovative, advancements and cutting-edge products.

As the city of Hyderabad welcomes numerous globally influential leaders, the event is all set to provide a fertile ground for knowledge exchange and innovation in the life sciences and biotechnology sector. BioAsia 2024 will also offer a worldwide platform for promising startups in the pharmaceutical, biotech, life sciences, health-tech, and med-tech sectors to showcase their inventive concepts, opined Industry experts.

“The 21st edition of BioAsia 2024 is certainly going to be a milestone event, as the presence of global leaders marks the vision to bridge the gaps in the healthcare industry and foster innovation in these critical sectors” noted Shakthi Nagappan, Director of Life Sciences, Govt. of Telangana and CEO of BioAsia.